{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:19:53Z","timestamp":1778098793004,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.virol.2025.110573","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:29:24Z","timestamp":1747250964000},"page":"110573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis"],"prefix":"10.1016","volume":"610","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3313-5900","authenticated-orcid":false,"given":"Stine Sofie Frank","family":"Lende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik Holm","family":"Rothemejer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malthe","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lange","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Traberg-Nyborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma Falling","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Karina","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Schmeltz","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariane H\u00f8gsbjerg","family":"Schleimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110573_bib1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/CVI.00572-14","article-title":"Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus","volume":"21","author":"Adam","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virol.2025.110573_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110573_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt.2618","article-title":"Broad protection against influenza infection by vectored immunoprophylaxis in mice","volume":"31","author":"Balazs","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2025.110573_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nm.3471","article-title":"Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission","volume":"20","author":"Balazs","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.virol.2025.110573_bib5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaip.2022.03.017","article-title":"Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency","volume":"10","author":"Barmettler","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.virol.2025.110573_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010183","article-title":"Influenza treatment: limitations of antiviral therapy and advantages of drug combination therapy","volume":"11","author":"Batool","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2025.110573_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virol.2025.110573_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/imr.12478","article-title":"Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention","volume":"275","author":"Brady","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2025.110573_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9662","article-title":"Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice","volume":"14","author":"Brady","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2025.110573_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110573_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2208822","article-title":"VV116 versus nirmatrelvir-ritonavir for oral treatment of covid-19","volume":"388","author":"Cao","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2025.110573_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01762-x","article-title":"Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial","author":"Casazza","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.virol.2025.110573_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/hum.2018.233","article-title":"Optimization of dexamethasone administration for maintaining global transduction efficacy of adeno-associated virus serotype 9","volume":"30","author":"Chai","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2025.110573_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/hum.2021.083","article-title":"Dexamethasone transiently enhances transgene expression in the liver when administered at late-phase post long-term adeno-associated virus transduction","volume":"33","author":"Chai","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2025.110573_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11030682","article-title":"SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight against the next pandemic","volume":"11","author":"Chakraborty","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2025.110573_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.virol.2025.110573_bib17","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciz638","article-title":"Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015","volume":"70","author":"Collins","year":"2020","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2025.110573_bib18","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2021.05.005","article-title":"Tackling COVID-19 with neutralizing monoclonal antibodies","volume":"184","author":"Corti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.virol.2025.110573_bib19","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-018-03665-3","article-title":"How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin","volume":"9","author":"Doud","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110573_bib20","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2025.110573_bib21","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2025.110573_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005090","article-title":"AAV-delivered antibody mediates significant protective effects against SIVmac239 challenge in the absence of neutralizing activity","volume":"11","author":"Fuchs","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2025.110573_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/hgtb.2019.031","article-title":"Two-dimensional droplet digital PCR as a tool for titration and integrity evaluation of recombinant adeno-associated viral vectors","volume":"30","author":"Furuta-Hanawa","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.virol.2025.110573_bib24","series-title":"0","volume":"vol. 53","author":"Garc\u00eas","year":"2017"},{"key":"10.1016\/j.virol.2025.110573_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12020154","article-title":"Prevention and treatment strategies for respiratory syncytial virus (RSV)","volume":"12","author":"Gatt","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2025.110573_bib26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear factor VIII expression after AAV gene transfer for hemophilia A","volume":"385","author":"George","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2025.110573_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ejh.13519","article-title":"SARS-CoV-2 infection among patients with haematological disorders: severity and one-month outcome in 66 Danish patients in a nationwide cohort study","volume":"106","author":"Glenthoj","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.virol.2025.110573_bib28","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","author":"Group","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2025.110573_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166032","article-title":"Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments","author":"Gupta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virol.2025.110573_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"Johnson","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.virol.2025.110573_bib31","article-title":"Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation","volume":"15","author":"Kaler","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.virol.2025.110573_bib32","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41467-020-17577-8","article-title":"A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.virol.2025.110573_bib33","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.virol.2025.110573_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","article-title":"Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors","volume":"14","author":"Kruzik","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.virol.2025.110573_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110573_bib36","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.virol.2025.110573_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291131","article-title":"Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster","volume":"18","author":"Lende","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110573_bib38","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/CVI.00545-13","article-title":"Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9","volume":"20","author":"Limberis","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virol.2025.110573_bib39","doi-asserted-by":"crossref","first-page":"187ra172","DOI":"10.1126\/scitranslmed.3006299","article-title":"Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza","volume":"5","author":"Limberis","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2025.110573_bib40","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/infdis\/jiw460","article-title":"Adeno-associated virus serotype 9-expressed ZMapp in mice confers protection against systemic and airway-acquired ebola virus infection","volume":"214","author":"Limberis","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110573_bib41","article-title":"Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza","volume":"5","author":"Limberis Maria","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2025.110573_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110573_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mt.2015.191","article-title":"Host anti-antibody responses following adeno-associated virus-mediated delivery of antibodies against HIV and SIV in rhesus monkeys","volume":"24","author":"Martinez-Navio","year":"2016","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.virol.2025.110573_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-associated virus delivery of anti-HIV monoclonal antibodies can drive long-term virologic suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2025.110573_bib45","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2025.110573_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.885672","article-title":"Immunogenicity of monoclonal antibodies and the potential use of HLA haplotypes to predict vulnerable patients","volume":"13","author":"Mosch","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2025.110573_bib47","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2025.110573_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.21.01891","article-title":"Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer: the CANVAX cohort study","volume":"40","author":"Naranbhai","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.virol.2025.110573_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103410","article-title":"SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity","volume":"68","author":"Nielsen","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virol.2025.110573_bib50","doi-asserted-by":"crossref","first-page":"ofad513","DOI":"10.1093\/ofid\/ofad513","article-title":"Systematic literature review of risk factors for poor outcomes among adults with respiratory syncytial virus infection in high-income countries","volume":"10","author":"Njue","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virol.2025.110573_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01273-23","article-title":"A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness","volume":"68","author":"Plotnik","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110573_bib52","volume":"vol. 2","author":"Ruysseveldt","year":"2021"},{"key":"10.1016\/j.virol.2025.110573_bib53","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1038\/s41467-023-40204-1","article-title":"Monoclonal antibody levels and protection from COVID-19","volume":"14","author":"Stadler","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110573_bib54","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41592-020-0889-6","article-title":"Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals","volume":"17","author":"Su","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.virol.2025.110573_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0023","article-title":"Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children: a systematic review and network meta-analysis","volume":"6","author":"Sun","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.virol.2025.110573_bib56","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMc2201933","article-title":"Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA.2","volume":"386","author":"Takashita","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2025.110573_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.chom.2014.04.009","article-title":"Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure","volume":"15","author":"Tharakaraman","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2025.110573_bib58","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/infdis\/jix644","article-title":"Intramuscular adeno-associated virus-mediated expression of monoclonal antibodies provides 100% protection against ebola virus infection in mice","volume":"217","author":"van Lieshout","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110573_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00195-7","article-title":"First RSV vaccine approvals","volume":"4","author":"Venkatesan","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virol.2025.110573_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2025.110573_bib61","doi-asserted-by":"crossref","first-page":"eabh1766","DOI":"10.1126\/science.abh1766","article-title":"Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110573_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007395","article-title":"Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge","volume":"14","author":"Welles","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2025.110573_bib63","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110573_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/imt.13.171","article-title":"Influenza vaccination in immunocompromised patients: efficacy and safety","volume":"6","author":"Zbinden","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.virol.2025.110573_bib65","first-page":"eaaj1928","volume":"vol. 9","author":"Zhu","year":"2017"},{"key":"10.1016\/j.virol.2025.110573_bib66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:53:00Z","timestamp":1753980780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":66,"alternative-id":["S0042682225001862"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110573","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110573"}}